Viemed Healthcare, Inc. (VMD) stock
VMDNasdaqServices-Misc Health & Allied Services, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 17/3018% below fair value
$8.78−0.29 (-3.20%)
Close on Nov 18, 2026Market cap $334.42MP/E 24.4Yield –
Viemed Healthcare free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Viemed Healthcare's free cash flow for the twelve months ending Jun 30, 2026 was $29.24M. For fiscal 2025 it was $11.93M, up 805.2% from the year before. The highest annual figure on record is $22.07M in fiscal 2020.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $11.93M | +805.2% |
| FY2024 | Dec 31, 2024 | $1.32M | -93.1% |
| FY2023 | Dec 31, 2023 | $19.12M | +294.2% |
| FY2022 | Dec 31, 2022 | $4.85M | +76.3% |
| FY2021 | Dec 31, 2021 | $2.75M | -87.5% |
| FY2020 | Dec 31, 2020 | $22.07M | +287.0% |
| FY2019 | Dec 31, 2019 | $5.70M | -64.9% |
| FY2018 | Dec 31, 2018 | $16.25M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $7.44M | +80.4% |
| Q1 FY2026 | Mar 31, 2026 | $1.36M | – |
| Q4 FY2025 | Dec 31, 2025 | $9.70M | +207.3% |
| Q3 FY2025 | Sep 30, 2025 | $10.73M | +515.7% |
| Q2 FY2025 | Jun 30, 2025 | $4.13M | +230.5% |
| Q1 FY2025 | Mar 31, 2025 | -$12.63M | – |
| Q4 FY2024 | Dec 31, 2024 | $3.16M | -41.0% |
| Q3 FY2024 | Sep 30, 2024 | $1.74M | -72.8% |
| Q2 FY2024 | Jun 30, 2024 | $1.25M | -19.2% |
| Q1 FY2024 | Mar 31, 2024 | -$4.83M | -183.1% |
| Q4 FY2023 | Dec 31, 2023 | $5.35M | +153.4% |
| Q3 FY2023 | Sep 30, 2023 | $6.41M | +291.9% |
| Q2 FY2023 | Jun 30, 2023 | $1.55M | – |
| Q1 FY2023 | Mar 31, 2023 | $5.82M | +82.7% |
| Q4 FY2022 | Dec 31, 2022 | $2.11M | +6.0% |
| Q3 FY2022 | Sep 30, 2022 | $1.64M | – |
| Q2 FY2022 | Jun 30, 2022 | -$2.08M | -322.9% |
| Q1 FY2022 | Mar 31, 2022 | $3.18M | +12.4% |
| Q4 FY2021 | Dec 31, 2021 | $1.99M | +109.5% |
| Q3 FY2021 | Sep 30, 2021 | -$3.01M | -161.9% |
| Q2 FY2021 | Jun 30, 2021 | $933.00K | -95.3% |
| Q1 FY2021 | Mar 31, 2021 | $2.83M | – |
| Q4 FY2020 | Dec 31, 2020 | $951.00K | -79.3% |
| Q3 FY2020 | Sep 30, 2020 | $4.86M | +70.9% |
| Q2 FY2020 | Jun 30, 2020 | $19.87M | – |
| Q1 FY2020 | Mar 31, 2020 | -$3.61M | -776.6% |
| Q4 FY2019 | Dec 31, 2019 | $4.60M | -18.9% |
| Q3 FY2019 | Sep 30, 2019 | $2.84M | -22.0% |
| Q2 FY2019 | Jun 30, 2019 | -$2.27M | – |
| Q1 FY2019 | Mar 31, 2019 | $534.00K | – |
| Q4 FY2018 | Dec 31, 2018 | $5.67M | – |
| Q3 FY2018 | Sep 30, 2018 | $3.64M | – |
See a number that looks wrong?